Wells Fargo
AYTU icon

Wells Fargo’s AYTU BioPharma AYTU Stock Holding History

Wells Fargo’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$347 Hold
127
– – ﹤0.01% 6426
2025
Q4 		$330 Hold
127
– – ﹤0.01% 6362
2025
Q3 		$239 Hold
127
– – ﹤0.01% 6335
2025
Q2 		$277 Buy
127
+3
+2% +$5 ﹤0.01% 6424
2025
Q1 		$148 Hold
124
– – ﹤0.01% 6346
2024
Q4 		$210 Hold
124
– – ﹤0.01% 6358
2024
Q3 		$291 Hold
124
– – ﹤0.01% 6206
2024
Q2 		$362 Sell
124
-40
-24% -$121 ﹤0.01% 6168
2024
Q1 		$498 Sell
164
-7
-4% -$20 ﹤0.01% 6277
2023
Q4 		$486 Buy
171
+14
+9% +$39 ﹤0.01% 6391
2023
Q3 		$423 Sell
157
-1
-0.6% -$2 ﹤0.01% 6399
2023
Q2 		$252 Buy
158
+5
+3% +$10 ﹤0.01% 6634
2023
Q1 		$342 Buy
153
+6
+4% +$18 ﹤0.01% 6631
2022
Q4 		$554 Buy
147
+1
+0.7% +$4 ﹤0.01% 6360
2022
Q3 		$0 Buy
146
+10
+7% +$76 ﹤0.01% 6648
2022
Q2 		$2K Hold
136
– – ﹤0.01% 6294
2022
Q1 		$3K Sell
136
-3
-2% -$75 ﹤0.01% 6566
2021
Q4 		$4K Sell
139
-17
-11% -$735 ﹤0.01% 6736
2021
Q3 		$9K Sell
156
-7
-4% -$525 ﹤0.01% 6230
2021
Q2 		$17K Sell
163
-395
-71% -$46.3K ﹤0.01% 5957
2021
Q1 		$85K Sell
558
-353
-39% -$56K ﹤0.01% 5559
2020
Q4 		$108K Buy
911
+199
+28% +$36.2K ﹤0.01% 5327
2020
Q3 		$169K Buy
712
+85
+14% +$21.8K ﹤0.01% 5032
2020
Q2 		$178K Buy
627
+626
+62,600% +$190K ﹤0.01% 4968
2020
Q1 		$0 Buy
+1
New +$193 ﹤0.01% 6186
2019
Q4 		– Hold
0
– – – 6346
2019
Q3 		– Hold
0
– – – 6366
2019
Q2 		– Hold
0
– – – 6353
2019
Q1 		– Hold
0
– – – 6039
2018
Q4 		– Hold
0
– – – 6381
2018
Q3 		– Hold
0
– – – 6383
2018
Q2 		– Hold
0
– – – 6316
2018
Q1 		– Hold
0
– – – 6353
2017
Q4 		– Hold
0
– – – 6335

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo's AYTU Position: Q1 2026 in Review

Wells Fargo held its AYTU BioPharma (AYTU) position steady in Q1 2026 at 127 shares worth $347. The position accounts for ﹤0.01% of the portfolio, ranked #6426.

Wells Fargo first reported a position in AYTU in Q1 2020 and has held it in 25 quarters since. The position peaked at $178K in Q2 2020. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • Wells Fargo held 127 shares of AYTU BioPharma worth $347 as of Q1 2026.
  • Wells Fargo left its AYTU BioPharma share count unchanged in Q1 2026.
  • AYTU BioPharma made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6426 holding.
  • Wells Fargo first reported a position in AYTU BioPharma in Q1 2020 and has held it in 25 quarters since.
  • Wells Fargo's AYTU BioPharma position peaked at $178K in Q2 2020.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.